Delivery Order SPE2DB20D3303-SPE2DB25FA0VR
Award Date 6/30/25
Potential Completion Date 7/22/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Zeposia 0.92 mg capsules. The contract has a firm fixed price of $13,862.79 and a performance period ending on July 30, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,862.79, is for the delivery of Zeposia 0.92 mg capsules. Zeposia is a medication used to treat certain neurological conditions. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2025. AmerisourceBergen Drug Corp also holds a larger Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,862.79 fixed-price contract is for the supply of the prescription medication Zeposia 0.92 mg capsules. The contract has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $13,399.71, is for the supply of Zeposia 0.92 mg capsules. Zeposia is a prescription medication used to treat certain medical conditions. The delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zeposia 0.92 mg capsules in 30-count packages, with a ceiling value of $4,620.93 and a final completion date of July 25, 2025. The contract is a firm-fixed-price type and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, with a ceiling value of $4,620.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Zeposia 0.92 mg capsules, a prescription medication, with a performance period through May 27, 2025. The contract is a Firm Fixed Price Delivery Order, and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order under contract SPE2DB24FJG97, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Zeposia 0.92 MG capsules, a specialty medication. The delivery order has a ceiling value of $26,799.42 and runs through August 9, 2024. AmerisourceBergen, a for-profit organization, was awarded this contract without any set-aside designation. This contract is part of a larger Indefinite...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,862.79, is for the delivery of Zeposia 0.92 mg capsules. It is a firm fixed-price Delivery Order contract with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $13,862.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Zeposia 0.92 MG Capsule 30S, with a completion date of May 1, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a contract ceiling value of $13,862.79. This competitive award, which carries a firm fixed-price structure and no set-aside designation, is scheduled for completion by September 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...